The Analysis of Patient Square Capital LP's Holdings
Currently, Patient Square Capital LP holds 28 types of securities in its portfolio with a total value $467.1M. In the most recent quarter, they have increased their positions in ONC (+69.3K shares, valued at $21.1M), MIRM (+194.4K shares, valued at $15.4M), TERN (+320.0K shares, valued at $12.9M); decreased their positions in ROIV (-4.3M shares, valued at $93.6M), INSM (-59.4K shares, valued at $10.3M), LQDA (-173.0K shares, valued at $6.0M); initiated new positions in ONC (+69.3K shares, valued at $21.1M), TERN (+320.0K shares, valued at $12.9M), COGT (+317.4K shares, valued at $11.3M). Stock Holdings
TickerCompany NameSharesShares âŗ%Event DateReport DateHistory
ROIV ROIVANT SCIENCES LTD8.2M shares-34.57%2025-12-312026-02-12
INSM INSMED INC267.0K shares-18.20%2025-12-312026-02-12 MIRM MIRUM PHARMACEUTICALS INC298.7K shares186.47%2025-12-312026-02-12 ARGX ARGENX SE26.0K shares67.74%2025-12-312026-02-12 ONC BEONE MEDICINES LTD69.3K sharesnew addition2025-12-312026-02-12 ABVX ABIVAX SA130.0K shares-14.38%2025-12-312026-02-12 PHVS PHARVARIS N V542.7K shares57.13%2025-12-312026-02-12 EYPT EYEPOINT INC780.0K shares-22.91%2025-12-312026-02-12 TERN TERNS PHARMACEUTICALS INC320.0K sharesnew addition2025-12-312026-02-12 CELC CELCUITY INC120.0K shares20.00%2025-12-312026-02-12 COGT COGENT BIOSCIENCES INC317.4K sharesnew addition2025-12-312026-02-12 KYMR KYMERA THERAPEUTICS INC139.0K shares50.12%2025-12-312026-02-12 LQDA LIQUIDIA CORPORATION227.0K shares-43.25%2025-12-312026-02-12 ALLO ALLOGENE THERAPEUTICS INC5.0M shares66.49%2025-12-312026-02-12 DNTH DIANTHUS THERAPEUTICS INC150.0K shares20.00%2025-12-312026-02-12 XENE XENON PHARMACEUTICALS INC136.5K sharesnew addition2025-12-312026-02-12 ARQT ARCUTIS BIOTHERAPEUTICS INC210.0K sharesnew addition2025-12-312026-02-12 OCUL OCULAR THERAPEUTIX INC490.0K shares-31.47%2025-12-312026-02-12 IRON DISC MEDICINE INC74.0K shares0.00%2025-12-312026-02-12 SYRE SPYRE THERAPEUTICS INC150.0K sharesnew addition2025-12-312026-02-12 ELVN ENLIVEN THERAPEUTICS INC308.1K shares22.84%2025-12-312026-02-12 AMLX AMYLYX PHARMACEUTICALS INC350.0K shares10.65%2025-12-312026-02-12 RCUS ARCUS BIOSCIENCES INC170.0K sharesnew addition2025-12-312026-02-12 CATX PERSPECTIVE THERAPEUTICS INC1.1M shares224.29%2025-12-312026-02-12 HROW HARROW INC7.0K sharesnew addition2025-12-312026-02-12 Call Option Holdings
No call option holdings data available
Put Option Holdings
No put option holdings data available